208 related articles for article (PubMed ID: 15280858)
1. Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life.
Ziemer M; Thiele JJ; Gruhn B; Elsner P
J Am Acad Dermatol; 2004 Aug; 51(2):318-9. PubMed ID: 15280858
[No Abstract] [Full Text] [Related]
2. [The skin manifestations of the graft vs. host reaction].
Biriukov AV; Baranov AE; Selidovkin GD; Evseeva LV; Getling ZM; Persina IS
Vestn Dermatol Venerol; 1990; (5):16-9. PubMed ID: 2402935
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of refractory joint contractures caused by sclerodermatous graft versus host disease.
Kim JB; Liakopoulou E; Watson JS
J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1235-8. PubMed ID: 17509955
[TBL] [Abstract][Full Text] [Related]
4. Chronic graft-versus-host disease treated with UVB phototherapy.
Enk CD; Elad S; Vexler A; Kapelushnik J; Gorodetsky R; Kirschbaum M
Bone Marrow Transplant; 1998 Dec; 22(12):1179-83. PubMed ID: 9894721
[TBL] [Abstract][Full Text] [Related]
5. Chronic graft-versus-host disease following allogeneic peripheral blood and bone marrow stem cell transplants: a single center experience.
Takami A; Ishiyama K; Asakura H; Shiobara S; Nakao S
Haematologica; 2002 Jun; 87(6):664-6. PubMed ID: 12031928
[No Abstract] [Full Text] [Related]
6. Acquired ichthyosis in bone marrow transplant recipients.
Spelman LJ; Strutton GM; Robertson IM; Weedon D
J Am Acad Dermatol; 1996 Jul; 35(1):17-20. PubMed ID: 8682957
[TBL] [Abstract][Full Text] [Related]
7. Atypical acute graft-versus-host disease.
Shin J; Hong W; Song H; Choi G; Kim YC
Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
[TBL] [Abstract][Full Text] [Related]
8. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
[TBL] [Abstract][Full Text] [Related]
9. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
[TBL] [Abstract][Full Text] [Related]
10. Generalized vitiligo after allogeneic bone marrow transplantation.
Cho SB; Roh MR; Chung KY; Lee KH; Park YK
Acta Derm Venereol; 2005; 85(1):82-3. PubMed ID: 15849005
[No Abstract] [Full Text] [Related]
11. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
[TBL] [Abstract][Full Text] [Related]
12. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
Sánchez-García J; Serrano J; Gómez P; Martínez F; Martín C; Román-Gómez J; Rodríguez A; Herrera C; García JM; Alvarez MA; Torres A
Haematologica; 2006 Mar; 91(3):340-7. PubMed ID: 16531257
[TBL] [Abstract][Full Text] [Related]
13. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
[TBL] [Abstract][Full Text] [Related]
14. Ocular manifestations of graft versus host disease following bone marrow transplantation.
Claes K; Kestelyn P
Bull Soc Belge Ophtalmol; 2000; (277):21-6. PubMed ID: 11126670
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion.
Voltarelli JC; Ahmed H; Paton EJ; Stracieri AB; Holman P; Bashey A; Coutinho M; Simoes BP; Ball ED; Carrier E
Bone Marrow Transplant; 2001 Jul; 28(1):97-9. PubMed ID: 11498752
[TBL] [Abstract][Full Text] [Related]
16. Acute graft-versus-host disease of the heart.
Roberts SS; Leeborg N; Loriaux M; Johnson FL; Huang ML; Stenzel P; Thiede C; Godder KT
Pediatr Blood Cancer; 2006 Oct; 47(5):624-8. PubMed ID: 16206193
[TBL] [Abstract][Full Text] [Related]
17. Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease.
Bonanomi S; Balduzzi A; Tagliabue A; Biagi E; Rovelli A; Corti P; Crippa D; Uderzo C
Bone Marrow Transplant; 2001 Sep; 28(6):631-2. PubMed ID: 11607781
[No Abstract] [Full Text] [Related]
18. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
Pavletic SZ; Smith LM; Bishop MR; Lynch JC; Tarantolo SR; Vose JM; Bierman PJ; Hadi A; Armitage JO; Kessinger A
Am J Hematol; 2005 Apr; 78(4):265-74. PubMed ID: 15795914
[TBL] [Abstract][Full Text] [Related]
19. Pediatric bone marrow transplantation.
Chan KW
Pediatr Dent; 1995; 17(4):291-3. PubMed ID: 7567633
[No Abstract] [Full Text] [Related]
20. Cutaneous acute graft-versus-host disease with isomorphic disposition over striae distensae in a 12-year-old girl.
García-Rodiño S; Sánchez-Aguilar D; Aliste C; Vázquez-Veiga H
Int J Dermatol; 2017 Feb; 56(2):e37-e38. PubMed ID: 27805255
[No Abstract] [Full Text] [Related]
[Next] [New Search]
